DD201142A5 - Verfahren zur herstellung von bistetrazolyl-methylsubstituierten cephalosporiantibiotika - Google Patents

Verfahren zur herstellung von bistetrazolyl-methylsubstituierten cephalosporiantibiotika Download PDF

Info

Publication number
DD201142A5
DD201142A5 DD81233364A DD23336481A DD201142A5 DD 201142 A5 DD201142 A5 DD 201142A5 DD 81233364 A DD81233364 A DD 81233364A DD 23336481 A DD23336481 A DD 23336481A DD 201142 A5 DD201142 A5 DD 201142A5
Authority
DD
German Democratic Republic
Prior art keywords
group
general formula
substituted
tetrazol
hydrogen
Prior art date
Application number
DD81233364A
Other languages
German (de)
English (en)
Inventor
Allen S Katner
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of DD201142A5 publication Critical patent/DD201142A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DD81233364A 1980-09-17 1981-09-17 Verfahren zur herstellung von bistetrazolyl-methylsubstituierten cephalosporiantibiotika DD201142A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/187,859 US4346076A (en) 1980-09-17 1980-09-17 Bis-tetrazoylmethyl substituted cephalosporin antibiotics

Publications (1)

Publication Number Publication Date
DD201142A5 true DD201142A5 (de) 1983-07-06

Family

ID=22690789

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81233364A DD201142A5 (de) 1980-09-17 1981-09-17 Verfahren zur herstellung von bistetrazolyl-methylsubstituierten cephalosporiantibiotika

Country Status (22)

Country Link
US (1) US4346076A (cs)
EP (1) EP0048169A3 (cs)
JP (1) JPS5781492A (cs)
KR (1) KR830007688A (cs)
AU (1) AU7528481A (cs)
CA (1) CA1174668A (cs)
CS (1) CS686781A2 (cs)
DD (1) DD201142A5 (cs)
DK (1) DK412181A (cs)
ES (1) ES505550A0 (cs)
FI (1) FI812782L (cs)
GB (1) GB2084144B (cs)
GR (1) GR74671B (cs)
HU (1) HU185954B (cs)
IL (1) IL63770A0 (cs)
PH (1) PH16985A (cs)
PL (1) PL132001B1 (cs)
PT (1) PT73680B (cs)
RO (1) RO82970B (cs)
SU (2) SU1087076A3 (cs)
YU (1) YU222681A (cs)
ZA (1) ZA816224B (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR850001206B1 (ko) * 1984-04-27 1985-08-20 한국과학기술원 세펨 유도체의 제조 방법
IT1181672B (it) * 1984-10-25 1987-09-30 Upjohn Co Cefalosporina alogenidrato cristallino
US4868193A (en) * 1986-09-24 1989-09-19 Rorer Pharmaceutical Corporation Styryl tetrazoles and anti-allergic use thereof
EP0333082A3 (en) * 1988-03-15 1991-05-02 Takeda Chemical Industries, Ltd. Cephem compounds, their production and use

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ176206A (en) * 1973-12-25 1978-03-06 Takeda Chemical Industries Ltd Cephalosporins
US4286089A (en) * 1974-12-27 1981-08-25 Smithkline Corporation 7-Acyl-3-(substituted tetrazolyl thiomethyl)cephalosporins
JPS525787A (en) * 1975-06-27 1977-01-17 Bristol Myers Co Antiibacterial agent
US4121040A (en) * 1976-02-17 1978-10-17 Pfizer Inc. 4-(Tetrazol-5-yl)-Δ3 -cephem compounds
US4109085A (en) * 1976-02-17 1978-08-22 Pfizer Inc. 7-amino-3-substituted-cephem compounds
US4278670A (en) * 1976-07-12 1981-07-14 Smithkline Corporation 7-Alpha-oxyiminoacylcephalosporins
US4129732A (en) * 1977-04-27 1978-12-12 Pfizer Inc. 4(Tetrazol-5-yl)-Δ3 -cephem compounds
FR2387235A1 (fr) * 1978-01-23 1978-11-10 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3,7-disubstitue-3-cephem-4-carboxylique et nouveaux produits ainsi obtenus, ayant une forte activite antibacterienne

Also Published As

Publication number Publication date
DK412181A (da) 1982-04-21
CA1174668A (en) 1984-09-18
US4346076A (en) 1982-08-24
PL132001B1 (en) 1985-01-31
EP0048169A2 (en) 1982-03-24
KR830007688A (ko) 1983-11-04
RO82970A (ro) 1984-01-14
RO82970B (ro) 1984-01-30
JPS5781492A (en) 1982-05-21
SU1087076A3 (ru) 1984-04-15
GB2084144B (en) 1985-02-06
PH16985A (en) 1984-05-04
PL233058A1 (cs) 1982-10-11
SU1119607A3 (ru) 1984-10-15
IL63770A0 (en) 1981-12-31
PT73680B (en) 1982-11-26
ES8306377A1 (es) 1983-05-16
AU7528481A (en) 1982-03-25
PT73680A (en) 1981-10-01
YU222681A (en) 1983-10-31
EP0048169A3 (en) 1983-01-19
CS686781A2 (en) 1985-06-13
GB2084144A (en) 1982-04-07
FI812782A7 (fi) 1982-03-18
HU185954B (en) 1985-04-28
ZA816224B (en) 1983-04-27
ES505550A0 (es) 1983-05-16
FI812782L (fi) 1982-03-18
GR74671B (cs) 1984-07-02

Similar Documents

Publication Publication Date Title
DE2727753C2 (cs)
DE2461478C2 (de) Cephalosporinderivate und Verfahren zu deren Herstellung
EP0034760B1 (de) Cephalosporinderivate, sie enthaltende pharmazeutische Präparate und Verfahren zu ihrer Herstellung
EP0005830B1 (de) Cephalosporinderivate, deren Herstellung und die entsprechenden pharmazeutischen Präparate
CH639666A5 (de) Cephalosporansaeurederivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung.
CH617202A5 (cs)
EP0137440A2 (de) Cephalosporinderivate und Verfahren zu ihrer Herstellung
CH641468A5 (de) Cephemderivate.
DE2538804C2 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Mittel
CH636359A5 (de) Bicyclische heteroderivate von ungesaettigten 7-acylamido-3-cephem-4-carbonsaeuren, sowie ihre herstellung und ihre verwendung zur herstellung pharmazeutischer praeparate.
DD139857A5 (de) Verfahren zur herstellung von cephalosporinderivaten
DE2225694A1 (de) Cephalosporinverbindungen und Ver fahren zu deren Herstellung
DD201142A5 (de) Verfahren zur herstellung von bistetrazolyl-methylsubstituierten cephalosporiantibiotika
DE2239947A1 (de) Cephalosporinverbindungen und verfahren zu deren herstellung
DE2203653A1 (de) Cephalosporincarbamate und Verfahren zu deren Herstellung
DE2714419C2 (de) Cephalosporinderivate, Verfahren zu deren Herstellung und Arzneimittel
EP0036652A2 (de) Cephalosporinderivate, entsprechende Präparate, die Verwendung dieser Produkte bei der Behandlung von Krankheiten, die Herstellung der Wirkstoffe sowie dabei anfallende Zwischenprodukte
DE2805590A1 (de) Pharmakologisch wirksame cephalosporinsaeurederivate, ihre verwendung in arzneimitteln und verfahren zu ihrer herstellung
CH634326A5 (de) 2-hydroxyiminoacetamido-cephemcarbonsaeuren und ihre herstellung.
US4107440A (en) Intermediates for preparing substituted phenylglycylcephalosporins
DE2404592C2 (de) In 3-Stellung thiolierte 7-Acyl-amidocephalosporansäurederivate, Verfahren zu deren Herstellung und sie enthaltende Mittel
DE2559932C2 (de) Cephalosporine, Verfahren zur Herstellung derselben und Mittel mit einem Gehalt derselben
DD200275A5 (de) Verfahren zur herstellung von in stellung 3 durch 1-cyanomethyl-1h-tetrazol-5-ylthiomethyl substituierten cephalosporinen
US4044047A (en) Intermediates for preparing substituted phenylglycylcephalosporins
DE2760488C2 (de) Cephalosporinderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel